Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(-)-17-(cyclopropylmethyl)-3,14 ß-dihydroxy-4,5 α-epoxy-6ß-[N-methyl-trans-3-(3-furyl) acrylamido] morphinan hydrochloride

EU orphan designation number: EU/3/02/115   
Active ingredient: (-)-17-(cyclopropylmethyl)-3,14 ß-dihydroxy-4,5 α-epoxy-6ß-[N-methyl-trans-3-(3-furyl) acrylamido] morphinan hydrochloride
Indication: Treatment of uremic pruritus
Sponsor: Toray International Europe GmbH
Hugenottenallee 175, 63263 Neu-Isenburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/09/2002 Orphan designation EMEA/OD/020/02 (2002)3404 of 11/09/2002
23/01/2008 Change of name and/or address of sponsor
26/01/2017 Change of name and/or address of sponsor
10/02/2017 Transfer of orphan designation EMA/OD/020/02 (2017)1049 of 08/02/2017